Compare Edwards Lifesciences Corporation Common Stock (EW) vs Prudential PLC (PUK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Edwards Lifesciences Corporation Common Stock vs Prudential PLC — how do they compare? Edwards Lifesciences Corporation Common Stock trades at $84.25 (market cap $49.44B), while Prudential PLC trades at $24.03 (market cap $28.76B). The key difference: Edwards Lifesciences Corporation Common Stock is the larger of the two by market cap, and Prudential PLC pays a 2.36% dividend while Edwards Lifesciences Corporation Common Stock pays none. Which is the better fit depends on your goals.
| EW | PUK | |
|---|---|---|
Market Cap | $49.44B | $28.76B |
Volume | 3,508,027 | 1,285,651 |
Sector | Health | Financials |
52-Week High | $95.18 | $33.61 |
52-Week Low | $72.65 | $23.54 |
Enterprise Value | $45.90B | $28.30B |
Typical Hold Time | — | 119 Days |
Dividend Yield | — | 2.36% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
PUK trades at $23.88, down 2.93% over 24 hours, amid a bearish technical signal. The company reported strong revenue growth to $27.39B in 2025 and net income of $3.98B, with a net margin of 14.52%. Recent earnings show mixed quarterly results, with two beats and two misses versus expectations. Analyst consensus is moderately bullish, with 50% buy ratings. The firm is executing a strategic overhaul, including a $3B capital rotation plan and exiting certain markets to sharpen focus.
The outlook is cautiously optimistic given solid profitability and strategic initiatives, but near-term headwinds include earnings volatility and bearish technical indicators. Risks involve execution of the restructuring and macroeconomic pressures. The stock presents a value opportunity with a low P/E of 8.28, though investors should weigh the mixed earnings record against growth prospects.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Edwards Lifesciences Corporation Common Stock
Edwards Lifesciences develops medical technologies for structural heart disease. Its products include transcatheter aortic-valve replacement, mitral and tricuspid therapies, and surgical structural-heart technologies.
Read more on EW →About Prudential PLC
Prudential is an Asia and Africa health and life insurance business and is focused on long-term savings. The business is increasingly focusing on digital offerings and creating strong brand equity and relationships with customers of its products through these.
Read more on PUK →
